Goldman Sachs Asset Management’ Minority Investment in Riverstone Holdings LLC

Simpson Thacher represented Riverstone Holdings LLC (“Riverstone”) in connection with the acquisition of a minority interest in Riverstone by Goldman Sachs Asset Management’s Petershill fund. Additional terms of the transaction were not disclosed. Riverstone is an energy and power-focused private investment firm that conducts buyout and growth capital investments in the energy industry. The Simpson […]

Outset Medical’s $76.5 Million Series C Equity Funding

Simpson Thacher is representing Warburg Pincus in connection with a $76.5 million Series C funding round for Outset Medical. A new investor, funds advised by T. Rowe Price Associates, Inc., led the round, with participation from existing investors including Warburg Pincus. Outset is a pioneering medical technology company focused on transforming the patient’s care experience […]

WellCare Health Plans, Inc.’s $800 Million Acquisition of Universal American Corp.

Paul, Weiss represented healthcare insurer Universal American Corp. in its completed acquisition by WellCare Health Plans, Inc. Under the terms of the acquisition, the completion of which was announced on April 28, Universal American stockholders received $10.00 in cash per share of common stock for a total transaction value of approximately $800 million. The Paul, […]

Planet Fitness’ $326 million Common Stock Secondary Offerings

Simpson Thacher represented J.P. Morgan Securities LLC, as underwriter, in two recent secondary offerings of Class A common stock of the Planet Fitness, Inc. In March 2017, the selling stockholders sold 15,000,000 shares in an offering for gross proceeds of approximately $307 million, and in May 2017 the selling stockholders sold 16,085,510 shares in an […]

J.F. Lehman & Company’s Acquisition of BEI Precision Systems & Space Company, Inc.

O’Melveny represented InnoVista Sensors Ltd. (InnoVista), a portfolio company of The Carlyle Group, PAI Partners, and Schneider Electric, in the sale of InnoVista’s subsidiary BEI Precision Systems & Space Company, Inc. (BEI PSSC) to investment affiliates of J.F. Lehman & Company. BEI PSSC is a leading provider of precision positioning sensor technologies, which it delivers […]

Bain Capital’s $3.2 Billion Acquisition of Sealed Air Corporation’s Diversey Care division

Citi is acting as financial advisor, and Skadden, Arps, Slate, Meagher & Flom LLP as legal advisor to Sealed Air. Barclays and RBC Capital Markets LLC are serving as financial advisors and Kirkland & Ellis LLP and Creel, García-Cuellar, Aiza y Enríquez are serving as legal counsel to Bain Capital Private Equity. Credit Suisse and […]

Healthcare Trust of America, Inc.’s $1.556 Million Common Shares Offering

Vinson & Elkins advised the underwriters in connection with Healthcare Trust of America, Inc.’s (HTA) underwritten public offering of 54,625,000 Class A Common Shares at a price to the public of $28.50 per share for an aggregate public offering price of $1,556,812,500. Wells Fargo Securities, J.P. Morgan, Morgan Stanley, BMO Capital Markets, Jefferies and Raymond […]

Comcast’s Agreement to Explore Wireless Opportunities with Charter

Davis Polk is advising Comcast Corporation on its announced agreement with Charter Communications, Inc. to explore potential opportunities for operational cooperation in their respective wireless businesses to accelerate and enhance each company’s ability to participate in the national wireless marketplace. The companies, which have each separately activated a mobile virtual network operator (MVNO) reseller agreement […]

Indiana Michigan Power Company’s $40 Million Tax-Exempt Remarketing

Hunton & Williams LLP acted as counsel to J.P. Morgan Securities LLC, as remarketing agent, for the remarketing of $40,000,000 aggregate principal amount of City of Rockport, Indiana Pollution Control Revenue Refunding Bonds (Indiana Michigan Power Company Project), Series D. Indiana Michigan Power Company is a subsidiary of American Electric Power Company, Inc. Indiana Michigan […]

AMAG Pharmaceuticals’ $300 Million Convertible Senior Notes Offering

Goodwin advised AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) in the completion of its $300 million aggregate principal amount of 3.25% convertible senior notes due 2022 in an underwritten public offering. Concurrently with the offering of the 2022 notes, AMAG entered into privately negotiated transactions with certain investors to repurchase approximately $158.9 million aggregate principal amount of […]